Amphastar Pharmaceuticals | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (38)

Latest Posts

About This Stock More About This Stock
3 Reasons Why Amphastar Is A Great Growth Stock
Article By: Zacks Investment Research
Tuesday, December 26, 2023 4:14 AM EST
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all.
In this article: AMPH
Read
These Three Biotech Stocks Are Trading At A Discount
Article By: The Tokenist
Thursday, November 23, 2023 6:02 PM EST
Investors exposed to the biotech sector have seen mixed results this year.
In this article: IMGN, AMPH, MRTX Also: PFE
Read
Revance, Amphastar Named Top 2020 Specialty Pharmaceuticals Ideas At Wells Fargo
Article By: The Fly
Wednesday, January 22, 2020 8:21 AM EST
Wells Fargo analyst Jacob Hughes named Revance Therapeutics and Amphastar Pharmaceuticals his top ideas for 2020 in the Specialty Pharmaceuticals space.
In this article: AMPH, RVNC Also: AGN, EBS, JAZZ, PRGO, TEVA, MNK, BHC, OSMT, KRTX
Read
Cempra Plunges To 52-Week Low, Shire Drug Label Expanded
Article By: Arpita Dutt
Friday, December 30, 2016 10:33 AM EST
It was a relatively slow week for pharma stocks though a couple of companies suffered regulatory setbacks with the FDA issuing complete response letters (CRLs) for their regulatory applications.
In this article: AMPH, AZN, BMY, CEMP, MRK, MYL, SHPG
Read
Your Complete Guide To The Generic Drug Industry
Article By: Zacks Investment Research
Wednesday, August 31, 2016 12:00 AM EST
With some diseases, the range of safe concentration levels is incredibly narrow, which could make switching from name-brand to generic dangerous. But most generics are safe, and cheaper.
In this article: AGN, NVS, AKRX, MYL, PRGO, TEVA, AXGN, AMPH, GNRX
Read

Latest Tweets for $AMPH

No tweets yet!

PARTNER HEADLINES